Literature DB >> 8524950

The production of TNF alpha and IL-8 in whole blood assays are differently regulated upon activation by LPS.

J M Cavaillon1, C Marie, C Pitton, C Fitting.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8524950

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN： 0361-7742


× No keyword cloud information.
  6 in total

1.  Presence of high levels of leukocyte-associated interleukin-8 upon cell activation and in patients with sepsis syndrome.

Authors:  C Marie; C Fitting; C Cheval; M R Losser; J Carlet; D Payen; K Foster; J M Cavaillon
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

2.  Lipopolysaccharide-induced cytokine cascade and lethality in LT alpha/TNF alpha-deficient mice.

Authors:  F Amiot; C Fitting; K J Tracey; J M Cavaillon; F Dautry
Journal:  Mol Med       Date:  1997-12       Impact factor: 6.354

3.  Inhibition of lipopolysaccharide-induced transcription factor Sp1 binding by spectrally pure diphosphoryl lipid A from Rhodobacter sphaeroides, protein kinase inhibitor H-8, and dexamethasone.

Authors:  B W Jarvis; N Qureshi
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

4.  A type 2 response in lipopolysaccharide (LPS)-stimulated whole blood cell cultures from periodontitis patients.

Authors:  S J Fokkema; B G Loos; C Slegte; U van der Velden
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

5.  Monocyte-derived RANTES is intrinsically elevated in periodontal disease while MCP-1 levels are related to inflammation and are inversely correlated with IL-12 levels.

Authors:  S J Fokkema; B G Loos; U van der Velden
Journal:  Clin Exp Immunol       Date:  2003-03       Impact factor: 4.330

6.  Involvement of mitogen-activated protein kinase pathways in interleukin-8 production by human monocytes and polymorphonuclear cells stimulated with lipopolysaccharide or Mycoplasma fermentans membrane lipoproteins.

Authors:  C Marie; S Roman-Roman; G Rawadi
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.